Keywords: International AIDS Conference, GlaxoSmithKline, Merck & Co, Abbott, Gilead, Isentress, Kaletra

Highlights from International AIDS conference include updates on S/GSK 1349572, Merck & Co’s Isentress, Abbott’s Kaletra and a microbial gel

Article | 20 July 2010

Print This

Developments in HIV/AIDS treatment were the focus of the International AIDS Conference in Vienna, Austria, over the last couple ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in